Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.43 |
| ▸ | FDPS | P14324 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30724801 | 0.85 | KDM1A (0.36) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| SCHEMBL5136231 | 0.83 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| SCHEMBL4608511 | 0.83 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| SCHEMBL5704674 | 0.82 | ALOX15 (0.46) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| SCHEMBL9578859 | 0.81 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| SCHEMBL1472117 | 0.81 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| SCHEMBL20608591 | 0.81 | ALOX15 (0.45) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| SCHEMBL16977250 | 0.81 | ALOX15 (0.61) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| SCHEMBL11209467 | 0.80 | ALOX15 (0.55) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| Formaldehyde SCHEMBL5704728 | 0.79 | ALOX15 (0.53) | ALOX15ALDH1A1GGPS1FDPSUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382252-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-12-18 | — | — | US | disclosed |
| EP-4547638-A1 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2025-05-07 | — | — | EP | disclosed |
| CN-119585235-A | Organic compound | 奇华顿股份有限公司 | 2025-03-07 | — | — | CN | disclosed |
| WO-2024000260-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-01-04 | — | — | WO | disclosed |
| WO-2024003176-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-01-04 | — | — | WO | disclosed |
| US-20170327449-A1 | NOVEL PROCESS FOR PREPARING SYNTHESIS INTERMEDIATES USING PRODUCTS OF NATURAL ORIGIN AND USE OF THE INTERMEDIATES OBTAINED | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2017-11-16 | — | — | US | disclosed |
| US-20170327449-A1 | NOVEL PROCESS FOR PREPARING SYNTHESIS INTERMEDIATES USING PRODUCTS OF NATURAL ORIGIN AND USE OF THE INTERMEDIATES OBTAINED | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2017-11-16 | — | — | US | disclosed |
| WO-2016097612-A1 | NOVEL PROCESS FOR PREPARING SYNTHESIS INTERMEDIATES USING PRODUCTS OF NATURAL ORIGIN AND USE OF THE INTERMEDIATES OBTAINED | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250382252-A1 | ORGANIC COMPOUNDS | OR10J3, TRPA1, OR51E2 | ALOX15 57/4885ALDH1A1 76/4885GGPS1 178/4885 |
| US-20170327449-A1 | NOVEL PROCESS FOR PREPARING SYNTHESIS INTERMEDIATES USING PRODUCTS OF NATURAL ORIGIN AND USE OF THE INTERMEDIATES OBTAINED | ADH7, ADH1B, ADH4 | ALOX15 564/4885ALDH1A1 133/4885GGPS1 134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.